Posted in | News | Business | Precious Metal

Ames Acquires Ferro’s North American, Asian Precious Metals Powders and Flakes Product Lines

Ferro Corporation (the “Company”) announced today that it has completed the sale of its precious metals-based powders and flakes product lines in North America and Asia to Ames Advanced Materials Corporation (“Ames”), a wholly-owned subsidiary of Ames Goldsmith Corporation, a major producer of precious metal products.

The transaction includes the manufacturing assets of the Company’s South Plainfield, New Jersey facility, including associated inventory, and also includes the assets of its precious metals powders and flakes business line in Tsukuba, Japan. Through September 2013, these precious metals powders and flakes operations had value-added sales of approximately $23 million.

In addition to the asset sale, Ferro and Ames also entered into a seven-year supply agreement. Through the supply agreement, Ferro secures a reliable source of key raw materials for its downstream businesses while protecting its cost position.

The net cash proceeds from the sale were approximately $13 million. In addition, Ames provided Ferro with precious metals valued at approximately $43 million to satisfy its outstanding precious metal lease obligations. Primarily as a result of the sale, Ferro’s current precious metal net lease obligations have been reduced to approximately $42 million compared with obligations of approximately $90 million at September 30, 2013. The Company estimates that the transaction, including the supply agreement, will result in a financial reporting gain in excess of the net cash proceeds and a tax loss estimated at approximately $5 million.

Commenting on the transaction, Peter Thomas, President and Chief Executive Officer of Ferro, said, “The sale of these assets is a result of our continuing business and asset portfolio evaluation process and the harvesting of underperforming and non-core businesses. This transaction allows us to redeploy assets into attractive growth opportunities. While the transaction will reduce projected value-added sales for the fourth quarter of 2013, we are not modifying our prior adjusted earnings guidance.”

The Ferro South Plainfield site and its approximately 160 employees join Ames as part of the transaction. The Ferro Tsukuba site and its employees remain with Ferro.

Mr. Thomas added, “On behalf of everyone at Ferro, I thank our team at South Plainfield for their many contributions. I am confident they will have exciting opportunities ahead.”

The transaction does not include the Company’s precious metals business in Hanau, Germany, which produces gold, palladium and platinum precious metal products. Hanau also will continue to produce silver products for current customers in Europe and for Ferro’s other businesses, primarily the Automotive Glass business.

The Company was advised by J.P. Morgan and Jones Day.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Vibrantz Technologies. (2019, February 08). Ames Acquires Ferro’s North American, Asian Precious Metals Powders and Flakes Product Lines. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=38866.

  • MLA

    Vibrantz Technologies. "Ames Acquires Ferro’s North American, Asian Precious Metals Powders and Flakes Product Lines". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=38866>.

  • Chicago

    Vibrantz Technologies. "Ames Acquires Ferro’s North American, Asian Precious Metals Powders and Flakes Product Lines". AZoM. https://www.azom.com/news.aspx?newsID=38866. (accessed November 21, 2024).

  • Harvard

    Vibrantz Technologies. 2019. Ames Acquires Ferro’s North American, Asian Precious Metals Powders and Flakes Product Lines. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=38866.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.